Gradalis® is leading a new way to fight cancer

Watch Carley’s story

Watch Ella’s story on CBS 11

Gradalis is developing and testing Vigil®, a fully personalized, patient-specific cancer immunotherapy that can be applied to virtually any cancer

Find out more about who we are, our leadership, and our board of directors

Discover how Vigil fights cancer through our unique process

We hire the best, and offer one of the best benefits packages available